Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of thymosin alpha 1 for the treatment of immunological diseases

Use of thymosin alpha 1 for the treatment of immunological diseases

US Patent 8022036 · Granted Sep 20, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thymosin alpha 1 for use in treatment of cystic fibrosis2024
Thymosin alpha 1 for use in treatment of cystic fibrosis2024
Thymosin alpha 1 for use in treatment of cystic fibrosis2022
Thymosin alpha 1 for use in treatment of cystic fibrosis2022
Indole-3-aldehyde for treating dysreactive immune disorders2020
Thymosin alpha 1 for use in treatment of cystic fibrosis2019
Thymosin alpha 1 for use in treatment of cystic fibrosis2019
Monoclonal antibody to human line-1 ORF2 protein and method for early detection 2019
Anti tumoral immunogenic peptides and vaccine thereof2015
Treatment of retroviral reservoirs exploiting oxidative stress2014
Use of IL-23 antagonists for treatment of infection2013
Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of in2013